Zhijia Wang

Zhijia Wang

Auto-generated profile, based on publicly available information

Zhijia Wang

School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Bioactive Materials
Verified
Journal Article
Open access
WPWenmin Pi
Wenmin Pi
LWLinying Wu
Linying Wu
JLJihui Lu
Jihui Lu
XLXiaoyu Lin
Xiaoyu Lin
XHXuemei Huang
Xuemei Huang
PWPenglong Wang
Penglong Wang
Tumor microenvironment (TME) plays an important role in the tumorigenesis, proliferation, invasion and metastasis. Thereby developing synergistic anticancer strategies with multiple mechanisms are urgent. Copper is widely used in the treatment of tumor chemodynamic therapy (CDT) due to its excellent laser-mediated photo-Fenton-like reaction. Additionally, copper can induce cell death through cuproptosis, which is a new modality different from the known death mechanisms and has great promise in tumor treatment. Herein, we report a natural small molecules carrier-free injectable hydrogel (NCTD Gel) consisted of Cu2+-mediated self-assembled glycyrrhizic acid (GA) and norcantharidin (NCTD), which are mainly governed by coordination and hydrogen bonds. Under 808 nm laser irradiation, NCTD Gel can produce reactive oxygen species (ROS), consume glutathione (GSH) and overcome hypoxia in TME, leading to synergistically regulate TME via apoptosis, cuproptosis and anti-inflammation. In addition, NCTD Gel's CDT display high selectivity and good biocompatibility as it relies on the weak acidity and H2O2 overexpression of TME. Notably, NCTD Gel's components are originated from clinical agents and its preparation process is easy, green and economical, without any excipients. This study provides a new carrier-free hydrogel synergistic antitumor strategy, which has a good prospect in industrial production and clinical transformation.

9 September 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZWZhijia Wang
Zhijia Wang
WLWen Li
Wen Li
JLJihui Lu
Jihui Lu
ZYZhihua Yuan
Zhihua Yuan
WPWenmin Pi
Wenmin Pi
PWPenglong Wang
Penglong Wang